Baloncibart

巴洛西拜单抗

Report date: 2025/11/10 15:47:15

Base Information

Drug NameBaloncibart
Drug Alias NameREGN-7544REGN7544
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionNatriuretic peptide receptor 1 inhibitors
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsHypotensionPostural Orthostatic Tachycardia Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRegeneron Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHypotensionPostural Orthostatic Tachycardia Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A